biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Denali & Bioasis why not

<< Previous

Bullboard Posts

Next >>

Comment by MineDiggeron Jul 30, 2021 3:51am

128 Views

Post# 33630850

RE:RE:RE:RE:RE:Denali & Bioasis why not

re "A better delivery system claimed by who?" maybe that was rhetorical? But for completeness:

"Outperforms all other BBB technologies, delivering a greater percentage of injected dose"

on Slide 3 of that well-out-of-date 2021-03-24 Corp Pres.

and then see the table on Slide 10 comparing Bioasis at 4-6% vs Denali, Genentech, Roche, Armagen and Angiochem in the 1 - 1.5% range.

Calling all Denali holders looking for something to do with your huge profits, please take a punt here!

MD

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario